Genmab’s Capital Markets Day registration site is hosted by Bizzabo, Inc. If you have any questions related to the hosting, please contact Bizzabo, Inc. This website uses cookies to track visitors’ use of the website so that performance of the site can be improved also to provide you with a better user experience. In addition some features require the installation of cookies on your computer in order to function properly. For an overview of the cookies and more information see https://www.bizzabo.com/cookie-policy.
On Friday, November 13, 2020, Genmab hosted a virtual Capital Markets Day (CMD) for investors and analysts.
The event was webcast live from Genmab’s state-of-the-art R&D Center in Utrecht, the Netherlands, and from its new offices and laboratory facilities in Princeton, NJ, US. The CMD featured Genmab’s Executive Management Team and a variety of Genmab speakers. The Team provided updates on Genmab’s business, the ways in which we are delivering on our promise, and how we are evolving into a fully integrated biotech.
Topics discussed included an overview of our robust pipeline with a focus on our exciting epcoritamab, tisotumab vedotin and DuoBody®-PD-L1x4-1BB programs, a deep dive into our proprietary DuoBody® technology, and a look at how we are growing our capabilities across the company.
The full broadcast is featured below, for your viewing. If you would like to download or view any of the individual presentations, you can do so by navigating to the Agenda page, and clicking on the individual session(s).
Our Speakers
For a copy of our privacy policy, please click here.